3D Printed Patient-Specific Resorbable Bone Scaffolds for Alveolar Bone Regeneration
10.1007/s13770-025-00773-2
- Author:
Puneet WADHWA
1
;
Ho-Kyung LIM
;
Hyon-Seok JANG
;
Eui-Seok LEE
Author Information
1. Department of Dentistry, Korea University Graduate School, Medicine, Seoul 02841, Republic of Korea
- Publication Type:REVIEW ARTICLE
- From:
Tissue Engineering and Regenerative Medicine
2026;23(1):85-106
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND:Alveolar bone loss following trauma, periodontal disease, congenital anomalies, or tooth extraction poses a major challenge for oral rehabilitation, especially in implant dentistry. Traditional grafting techniques using autografts, allografts, or xenografts provide limited predictability due to issues of resorption, donor morbidity, and immune incompatibility. Advances in three-dimensional (3D) printing now enable preparation of patient-specific biodegradable scaffolds designed using 3D imaging, like cone beam computed tomography (CBCT) and computer-aided design (CAD), allowing precise replication of defect geometry and tailored biological performance.
METHODS:This review article summarizes the most recent preclinical and clinical studies investigating biodegradable 3D printed scaffolds for alveolar bone regeneration. Studies were searched in the PubMed database, Scopus, and Google Scholar with the most relevant keywords related to 3D printed scaffolds focusing on alveolar bone regeneration.
RESULTS:Polymers such as PLA, PCL, and PLGA offer mechanical stability and printability but require bioactive modification. Ceramics, including hydroxyapatite and tricalcium phosphate, provide osteoconductivity yet are brittle.Hydrogels such as gelatin and alginate support cellular viability but lack structural strength. Composite scaffolds integrating polymers with ceramics or bioactive agents demonstrated superior osteogenic potential. Clinical applications included alveolar ridge preservation, guided bone regeneration, cleft repair, and implant site reconstruction. Emerging strategies utilizing bioinks with stem cells and growth factors further enhanced the biological properties of patient-specific 3D printed scaffolds for clinical purposes.
CONCLUSION:3D printed patient-specific biodegradable scaffolds represent a promising alternative to conventional grafting, offering precise defect reconstruction, improved biological integration, and translational potential in maxillofacial surgery. Continued optimization of material printing combinations and vascularization strategies will be critical to achieving long-term clinical success.
